Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Anixa Biosciences
Deal Size : Undisclosed
Deal Type : Collaboration
Anixa Biosciences and OntoChem Announce Collaboration to Develop Novel COVID-19 Therapeutics
Details : The strategic collaboration focuses on discovery and development of anti-viral drug candidates for COVID-19.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
April 20, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Anixa Biosciences
Deal Size : Undisclosed
Deal Type : Collaboration